Furthermore, CAF-derived BDNF promotes chemoresistance to anlotinib in GC cells via TrkB stimulation; thus, blocking the BDNF/TrkB pathway can induce CAFs to effectively overcome anlotinib resistance [73]. Here, NTRK2 is linked to gastric cancer.